U.S. markets closed
  • S&P 500

    3,963.51
    +29.59 (+0.75%)
     
  • Dow 30

    33,781.48
    +183.56 (+0.55%)
     
  • Nasdaq

    11,082.00
    +123.45 (+1.13%)
     
  • Russell 2000

    1,818.29
    +11.39 (+0.63%)
     
  • Crude Oil

    72.03
    +0.57 (+0.80%)
     
  • Gold

    1,801.00
    -0.50 (-0.03%)
     
  • Silver

    23.30
    +0.05 (+0.23%)
     
  • EUR/USD

    1.0559
    +0.0044 (+0.42%)
     
  • 10-Yr Bond

    3.4910
    +0.0830 (+2.44%)
     
  • GBP/USD

    1.2232
    +0.0027 (+0.22%)
     
  • USD/JPY

    136.6000
    +0.0760 (+0.06%)
     
  • BTC-USD

    17,232.15
    +384.80 (+2.28%)
     
  • CMC Crypto 200

    405.01
    +10.32 (+2.62%)
     
  • FTSE 100

    7,472.17
    -17.02 (-0.23%)
     
  • Nikkei 225

    27,574.43
    -111.97 (-0.40%)
     

Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity

Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity

Mounjaro, the brand-new Type 2 diabetes therapy, brought in $187.3 million in sales in its first full quarter on the market